The Knack on Female Stress Urinary Incontinence

Status Completed

Clinical Trial Summary

The aim of the present study is to test the hypothesis that voluntary pelvic floor muscle pre-contraction (the Knack) (alone) can be a treatment for urine leakage during efforts. For this purpose, the following parameters will be analysed and compared amongst 1) the Knack, 2) pelvic floor muscle training and 3) the Knack + pelvic floor muscle training groups: urine leakage as assessed by the pad test, urinary symptoms, muscle function, quality of life, subjective cure, adherence to exercises in the outpatient setting and at home and perceived self-efficacy of pelvic floor muscle exercises. The study population will comprise women with mild to moderate stress urinary incontinence or mixed urinary incontinente (with predominant stress urinary incontinence) as assessed by means of the one-hour pad test (leakage ≥2 g). Leakage up to 10 grams will be rated mild stress urinary incontinence and of 11 to 50 grams as moderate stress urinary incontinence. The sample will also include women with grade 2 muscle strength (normal contraction with elevation of the anterior vaginal wall) on the two-finger assessment rated according to the Oxford scale. The primary outcome measure will be the objective cure of urinary incontinence as assessed by means of the one-hour pad test three months after randomization. Secondary outcome measures: three-day bladder diary, 1 hour pad test, International Consultation on Incontinence Questionnaire - Short Form, Incontinence Quality of Life Questionnaire, Subjective cure of stress urinary incontinence, Self-efficacy/outcome expectation to pelvic floor muscle exercises, Frequency of the outpatient sessions, adherence to home exercises and pelvic floor muscle function, morphometry, strength and vaginal squeeze pressure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03722719
Study type	Interventional
Source	Federal University of São Paulo
Contact
Status	Completed
Phase	N/A
Start date	November 1, 2018
Completion date	February 29, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02001714` - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms	N/A
Not yet recruiting	`NCT00523068` - Pharmacological vs Surgical Treatment for Mixed Incontinence	Phase 4
Completed	`NCT00904969` - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence	N/A
Completed	`NCT00190814` - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.	Phase 3
Completed	`NCT00190827` - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)	Phase 3
Terminated	`NCT00247286` - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.	Phase 4
Completed	`NCT01959347` - Combined Treatment for Mixed Incontinence	Phase 3
Completed	`NCT00244296` - To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms	Phase 4
Not yet recruiting	`NCT05570071` - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI.	N/A
Completed	`NCT02334878` - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence	Phase 3
Completed	`NCT01382602` - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study	Phase 3
Completed	`NCT03296462` - Hip External Rotation Physical Therapy Trial	N/A
Recruiting	`NCT02750878` - Surgical Consent Process for Trans-obturator Tape Slings.	N/A
Completed	`NCT02296099` - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence	Phase 4
Completed	`NCT02599051` - Transobturator Verus Single Incision Slings	N/A
Completed	`NCT00138749` - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.	Phase 2
Terminated	`NCT03614611` - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence	N/A
Active, not recruiting	`NCT02275728` - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence	N/A
Terminated	`NCT01358214` - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape)	N/A
Active, not recruiting	`NCT01323426` - Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter.	Phase 1/Phase 2